Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters.
暂无分享,去创建一个
R. G. York | J. Butenhoff | K. Hansen | John L Butenhoff | Deanna J Luebker | Raymond G York | John A Moore | Kristen J Hansen | J. Moore
[1] S. Sheardown,et al. HMG-CoA reductase mRNA in the post-implantation rat embryo studied by in situ hybridization. , 1993, Teratology.
[2] H. Hers,et al. Glycogen metabolism in the liver of the foetal rat. , 1974, The Biochemical journal.
[3] Division on Earth. Guide for the Care and Use of Laboratory Animals , 1996 .
[4] John P Giesy,et al. Perfluorooctanesulfonate and related fluorinated hydrocarbons in marine mammals, fishes, and birds from coasts of the Baltic and the Mediterranean Seas. , 2002, Environmental science & technology.
[5] Nicos Christofides,et al. Serum thyroxine binding capacity-dependent bias in an automated free thyroxine assay. , 1999, Journal of immunoassay.
[6] J. S. Eldridge,et al. Quantitative characterization of trace levels of PFOS and PFOA in the Tennessee River. , 2002, Environmental science & technology.
[7] R. G. York,et al. Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. , 2005, Toxicology.
[8] C. Elcombe,et al. Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. , 2003, Toxicology.
[9] I. Chopra. Euthyroid Sick Syndrome: Is It a Misnomer? , 1997 .
[10] Jeffrey H Mandel,et al. Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals. , 2003, Environmental science & technology.
[11] J. Medina,et al. Postnatal hypoglycaemia and gluconeogenesis in the newborn rat. Delayed onset of gluconeogenesis in prematurely delivered newborns. , 1983, The Biochemical journal.
[12] D. McNamara,et al. Dietary regulation of maternal and fetal cholesterol metabolism in the guinea pig. , 1991, Biochimica et biophysica acta.
[13] S. Siegel,et al. Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.
[14] M. Obregon,et al. Effects of maternal hypothyroidism on the weight and thyroid hormone content of rat embryonic tissues, before and after onset of fetal thyroid function. , 1985, Endocrinology.
[15] A. Swank,et al. Metabolism, microflora effects, and genotoxicity in haloacetic acid-treated cultures of rat cecal microbiota. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[16] J. Dietschy,et al. Sterol synthesis and low density lipoprotein clearance in vivo in the pregnant rat, placenta, and fetus. Sources for tissue cholesterol during fetal development. , 1988, The Journal of clinical investigation.
[17] R. Sapin,et al. Free thyroxine measured by equilibrium dialysis and nine immunoassays in sera with various serum thyroxine-binding capacities. , 2003, Clinical chemistry.
[18] F. Labrie,et al. Development of the hypothalamic-pituitary-thyroid axis in the neonatal rat. , 1975, Endocrinology.
[19] Jeffrey H Mandel,et al. Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. , 2003, Environmental health perspectives.
[20] Kouji Harada,et al. The Influence of Time, Sex and Geographic Factors on Levels of Perfluorooctane Sulfonate and Perfluorooctanoate in Human Serum over the Last 25 years , 2004, Journal of occupational health.
[21] J. Peterson,et al. Evaluation of the hexokinase-glucose-6-phosphate dehydrogenase method of determination of glucose in urine. , 1968, Analytical biochemistry.
[22] S. Prahalada,et al. Preclinical evaluation of lovastatin. , 1988, The American journal of cardiology.
[23] J. D. Neill,et al. The Physiology of reproduction , 1988 .
[24] R. B. Wilcox,et al. Variable underestimates by serum free thyroxine (T4) immunoassays of free T4 concentrations in simple solutions. , 1994, The Journal of clinical endocrinology and metabolism.
[25] J. Giesy,et al. Peer Reviewed: Perfluorochemical Surfactants in the Environment , 2002 .
[26] C. Lau,et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[27] R. Margolis. Regulation of hepatic glycogen metabolism in pre- and postnatal rats. , 1983, Endocrinology.
[28] G. W. Snedecor. STATISTICAL METHODS , 1967 .
[29] R. Kumar,et al. Altered maternal thyroid function: fetal and neonatal development of rat. , 1989, Indian journal of physiology and pharmacology.
[30] Anders Bignert,et al. Temporal trends of PFOS and PFOA in guillemot eggs from the Baltic Sea, 1968--2003. , 2005, Environmental science & technology.
[31] J. Henck,et al. Pre- and postnatal toxicity of the HMG-CoA reductase inhibitor atorvastatin in rats. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.
[32] S. Colowick,et al. Methods in Enzymology , Vol , 1966 .
[33] J. Giesy,et al. Global distribution of perfluorooctane sulfonate in wildlife. , 2001, Environmental science & technology.
[34] M. Obregon,et al. Transfer of thyroxine from the mother to the rat fetus near term: effects on brain 3,5,3'-triiodothyronine deficiency. , 1988, Endocrinology.
[35] R. Margolis,et al. Glycogen metabolism in neonatal liver of the rat. , 1986, Archives of biochemistry and biophysics.
[36] C. Lau,et al. Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. , 2005, Birth defects research. Part B, Developmental and reproductive toxicology.
[37] K. Hellestrand. Intravenous flecainide acetate for supraventricular tachycardias. , 1988, The American journal of cardiology.
[38] R. B. Wilcox,et al. Underestimates of serum free thyroxine (T4) concentrations by free T4 immunoassays. , 1994, The Journal of clinical endocrinology and metabolism.
[39] John P Giesy,et al. Concentrations of perfluorinated acids in livers of birds from Japan and Korea. , 2002, Chemosphere.
[40] B. Shapiro,et al. Thyroxine and palatal development in rat embryos. , 1975, Developmental biology.
[41] M. Obregon,et al. L-thyroxine and 3,5,3'-triiodo-L-thyronine in rat embryos before onset of fetal thyroid function. , 1984, Endocrinology.
[42] C. Lau,et al. Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. , 2003, Birth defects research. Part B, Developmental and reproductive toxicology.
[43] J. Schlienger,et al. Dosages de thyroxine (T4) et tri-iodothyronine (T3) : techniques et place dans le bilan thyroïdien fonctionnel , 2003 .
[44] A. Calafat,et al. Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk. , 2004, Environmental science & technology.
[45] R. Cox,et al. Prevention of fluvastatin-induced toxicity, mortality, and cardiac myopathy in pregnant rats by mevalonic acid supplementation. , 1994, Teratology.
[46] K. Helzlsouer,et al. Historical Comparison of Perfluorooctanesulfonate, Perfluorooctanoate, and Other Fluorochemicals in Human Blood , 2005, Environmental health perspectives.
[47] P. Trinder. Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor , 1969 .
[48] J. Giesy,et al. OTHER HALOGENATED POPs OF CONCERN LEVELS OF PERFLUOROOCTANE SULFONATE (PFOS) AND OTHER RELATED COMPOUNDS IN THE BLOOD OF JAPANESE PEOPLE , 2002 .
[49] C. Dunnett. A Multiple Comparison Procedure for Comparing Several Treatments with a Control , 1955 .
[50] Scott A Mabury,et al. Collection of airborne fluorinated organics and analysis by gas chromatography/chemical ionization mass spectrometry. , 2002, Analytical chemistry.
[51] R. Ekins,et al. Uptake and metabolism of thyroid hormones by the rat foetus in early pregnancy. , 1984, Clinical science.
[52] M. Feigelson,et al. Effects of maternal diabetes on the development of carbohydrate metabolizing enzymes in fetal rat liver. , 1981, Archives of biochemistry and biophysics.
[53] Fumio Okada,et al. Perfluorooctane Sulfonate (PFOS) and Related Perfluorinated Compounds in Human Maternal and Cord Blood Samples: Assessment of PFOS Exposure in a Susceptible Population during Pregnancy , 2004, Environmental health perspectives.
[54] N. Bashan,et al. Rat liver glycogen metabolism in the perinatal period. , 1979, Biochimica et biophysica acta.
[55] M. Surani,et al. Mevalonate reverses the developmental arrest of preimplantation mouse embryos by Compactin, an inhibitor of HMG Co A reductase. , 1983, Journal of embryology and experimental morphology.
[56] John P Giesy,et al. Perfluorooctanesulfonate and related fluorinated hydrocarbons in mink and river otters from the United States. , 2002, Environmental science & technology.
[57] Nicos Christofides,et al. Assessment of serum thyroxine binding capacity-dependent biases in free thyroxine assays. , 1999, Clinical chemistry.
[58] Nathan M. Bass,et al. Interactions of flurochemicals with rat liver fatty acid-binding protein , 2002 .
[59] Paul D. Jones,et al. Accumulation of perfluorooctane sulfonate in marine mammals. , 2001, Environmental science & technology.
[60] W. C. Guenther,et al. Analysis of variance , 1968, The Mathematical Gazette.
[61] G. Olsen,et al. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[62] R. Robertson,et al. Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase. , 1983, Teratology.
[63] Scott A Mabury,et al. Identification of long-chain perfluorinated acids in biota from the Canadian Arctic. , 2004, Environmental science & technology.
[64] N. Terao,et al. Free thyroxine concentrations in serum measured by equilibrium dialysis in chronic renal failure. , 1996, Clinical chemistry.
[65] O. J. Dunn. Multiple Comparisons Using Rank Sums , 1964 .
[66] J. Johnson,et al. Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C]perfluorooctanoate or potassium [14C]perfluorooctanesulfonate. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[67] R. Sapin. Serum thyroxine binding capacity-dependent bias in five free thyroxine immunoassays: assessment with serum dilution experiments and impact on diagnostic performance. , 2001, Clinical biochemistry.
[68] C. Lau,et al. The developmental toxicity of perfluoroalkyl acids and their derivatives. , 2004, Toxicology and applied pharmacology.
[69] R. Glaser. Bartlett's Test of Homogeneity of Variances , 2004 .
[70] J. H. Roe,et al. Determination of glycogen with the anthrone reagent. , 1966, Analytical biochemistry.
[71] K. Hansen,et al. Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. , 2001, Environmental science & technology.
[72] R. Ravel,et al. Clinical Laboratory Medicine. Clinical Application of Laboratory Data , 1979 .
[73] Timothy R. Church,et al. Quantitative Evaluation of Perfluorooctanesulfonate (PFOS) and Other Fluorochemicals in the Serum of Children , 2004 .
[74] K. Koski,et al. Postnatal profiles of glycogenolysis and gluconeogenesis are modified in rat pups by maternal dietary glucose restriction. , 1999, The Journal of nutrition.
[75] J. Nelson,et al. The dual role of mevalonate in the cell cycle. , 1983, The Journal of biological chemistry.
[76] D. Kornbrust,et al. Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits. , 1989, The Journal of pharmacology and experimental therapeutics.
[77] Jeffrey H Mandel,et al. Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington. , 2004, Chemosphere.
[78] M. Stanton,et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[79] O. Spydevold,et al. The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid. , 1992, Biochimica et biophysica acta.
[80] R. Ekins. Analytic measurements of free thyroxine. , 1993, Clinics in laboratory medicine.
[81] H. Brewer,et al. Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin. , 1987, Journal of Clinical Endocrinology and Metabolism.